1. Analyst View 2. Research Methodology 3. Genetic Testing Overview 3.1 Applications and Advantages 3.2 Methods 3.3 Genetic Testing Laboratories - Unmet Need Analysis 4. Industry Overview 4.1 Drivers 4.1.1 Rising Incidence of Chronic Diseases 4.1.2 Growth in Ageing Population 4.1.3 Increasing Government Initiatives 4.1.4 Rising Investments in Genetic Testing Market 4.1.5 Incessant Launch of New Genetic Tests 4.2 Challenges 4.2.1 Low Awareness for Genetic Testing in Developing Countries 4.2.2 High Cost of Genetic Tests 4.2.3 Varying Reimbursement Policies 4.2.4 Ethical and Policy Issues 4.3 Opportunities 4.3.1 Next-Generation Sequencing (NGS) 4.3.2 Non-Invasive Prenatal Testing (NIPT) 4.3.3 Whole Genome Sequencing (WGS) for Cancer 4.3.4 Personalized Medicine 4.4 Trends 4.4.1 Genetic Testing in Oncology: Gaining Momentum 4.4.2 Strong Demand for Pharmacogenomics 4.4.3 At-Home DNA Tests or Direct-To-Consumer (DTC) Genetic Tests 5. Global Genetic Testing Market Outlook 6. Global Genetic Testing Market by Application 6.1 Carrier Testing 6.2 Diagnostic Testing 6.3 New Born Screening 6.4 Predictive & Pre-Symptomatic Testing 6.5 Prenatal Testing 6.6 Others 7. Global Genetic Testing Market by Disease 7.1 Alzheimer's Disease 7.2 Cystic Fibrosis 7.3 Cancer 7.4 Down Syndrome 7.5 Others 8. Global Genetic Testing Market by Geography 8.1 North America 8.2 Europe 8.3 Asia Pacific 8.4 Rest of the World (RoW) 9. Genetic Testing Regulations 10. Mergers & Acquisitions 11. Company Profiles (Overview, Product Offering, Financials, Developments, Strength & Weakness) 11.1 Abbott Laboratories 11.2 Roche Diagnostics 11.3 Myriad Genetics, Inc. 11.4 Thermo Fisher Scientific, Inc. 11.5 Agilent Technologies, Inc. 11.6 Hologic, Inc. 11.7 Illumina, Inc. 11.8 QIAGEN N.V. 11.9 Cepheid 11.10 Quest Diagnostics

List of Tables: Table 4-1: FDA Approved Pharmacogenomic Biomarkers Table 4-2: Key DTC Genetic Testing Companies by Category Table 4-3: Key Test Areas Offered in DTC Genetic Testing Segment Table 5-1: Global - Number of Disorders, Genes & Laboratories for Genetic Testing Table 8-1: North America - Number of Disorders, Genes & Laboratories for Genetic Testing Table 8-2: Europe - Number of Disorders, Genes & Laboratories for Genetic Testing Table 8-3: Asia-Pacific - Number of Disorders, Genes & Laboratories for Genetic Testing Table 8-4: Rest of the World - Number of Disorders, Genes & Laboratories for Genetic Testing Table 11-1: Abbott Laboratories - Key Gene Based Products Table 11-2: Abbott Laboratories – Net Sales (Million US$), 2015-2017 Table 11-3: Roche Molecular Diagnostics - Key Gene Based Products Table 11-4: Roche Diagnostics - Net Sales (Million US$), 2015-2017 Table 11-5: Myriad Genetics, Inc. - Key Gene Based Products Table 11-6: Myriad Genetics, Inc. - Key Financials (Million US$), 2015-2017 Table 11-7: Thermo Fisher Scientific Inc. - Key Gene Based Products Table 11-8: Thermo Fisher Scientific, Inc. - Net Sales (Million US$), 2015-2017 Table 11-9: Agilent Technologies, Inc. - Key Gene Based Products Table 11-10: Agilent Technologies, Inc. – Total Revenue (Million US$), 2015-2017 Table 11-11: Hologic, Inc. - Key Gene Based Products Table 11-12: Hologic, Inc. - Financial Performance (Million US$), 2015-2017 Table 11-13: Illumina, Inc. - Key Gene Based Products Table 11-14: Illumina, Inc. – Total Revenue (Million US$), 2016 & 2017 Table 11-15: QIAGEN N.V. - Key Gene Based Products Table 11-16: QIAGEN N.V. - Net Sales (Million US$), 2015-2017 Table 11-17: Cepheid - Key Gene Based Products Table 11-18: Quest Diagnostics - Key Gene Based Products Table 11-19: Quest Diagnostics - Financial Performance (Million US$), 2015-2017 List of Figures: Figure 4-1: Global - Population above 60 Years (Billion), 2013 & 2050 Figure 4 2: Organizational Transformation to Support Personalized Medicine Figure 5-1: Global - Genetic Testing Market (Billion US$), 2017-2022 Figure 5-2: Number of Disorders, Genes, Labs for Genetic Testing, 2015-2018 Figure 5-3: Number of Genetic Tests Performed, 2015-2018 Figure 5-4: Global - Breakup of Genetic Tests by Type (%) Figure 6-1: Global - Genetic Testing Market Segmentation by Applications (%), 2017 Figure 6-2: Global - Genetic Testing Market Segmentation by Applications (%), 2022 Figure 6-3: Global - Carrier Testing Market (Billion US$), 2017-2022 Figure 6-4: Global - Diagnostic Testing Market (Billion US$), 2017-2022 Figure 6-5: Global - New Born Screening Market (Billion US$), 2017-2022 Figure 6-6: Global - Predictive & Pre-Symptomatic Testing Market (Billion US$), 2017-2022 Figure 6-7: Global - Prenatal Testing Market (Billion US$), 2017-2022 Figure 6-8: Global - Other Application Market (Billion US$), 2017-2022 Figure 7-1: Global - Genetic Testing Market Segmentation by Disease (%), 2017 Figure 7-2: Global - Genetic Testing Market Segmentation by Disease (%), 2022 Figure 7-3: Global - Alzheimer's Disease Testing Market (Billion US$), 2017-2022 Figure 7-4: Global - Cystic Fibrosis Testing Market (Billion US$), 2017-2022 Figure 7-5: Global - Cancer Testing Market (Billion US$), 2017-2022 Figure 7-6: Global - Down Syndrome Testing Market (Billion US$), 2017-2022 Figure 7-7: Global - Other Disease Market (Billion US$), 2017-2022 Figure 8-1: Global - Genetic Testing Market Segmentation by Geography (%), 2017 Figure 8-2: Global - Genetic Testing Market Segmentation by Geography (%), 2022 Figure 8-3: North America - Genetic Testing Market (Billion US$), 2017-2022 Figure 8-4: North America - Breakup of Genetic Test by Type (%) Figure 8-5: Europe - Genetic Testing Market (Billion US$), 2017-2022 Figure 8-6: Europe - Breakup of Genetic Test by Type (%) Figure 8-7: Asia-Pacific - Genetic Testing Market (Billion US$), 2017-2022 Figure 8-8: Asia-Pacific - Breakup of Genetic Test by Type (%) Figure 8-9: Rest of the World - Genetic Testing Market (Billion US$), 2017-2022 Figure 8-10: Rest of the World - Breakup of Genetic Test by Type (%) Figure 9-1: Genetic Testing Regulatory Agencies Figure 11-1: Abbott Laboratories - Revenue Breakup by Segments (%), 2017 Figure 11-2: Abbott Laboratories - Revenue Breakup by Geography (%), 2017 Figure 11-3: Roche Diagnostics - Revenue Breakup by Business Segments (%), 2017 Figure 11-4: Roche Diagnostics - Revenue Breakup by Geography (%), 2017 Figure 11-5: Myriad Genetics, Inc. - Revenue Breakup by Business Segments (%), 2017 Figure 11-6: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2017 Figure 11-7: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017 Figure 11-8: Agilent Technologies, Inc. - Revenue Breakup by Segments (%), 2017 Figure 11-9: Agilent Technologies, Inc. - Revenue Breakup by Geography (%), 2017 Figure 11-10: Hologic, Inc. – Product Revenue Breakup by Segments (%), 2017 Figure 11-11: Hologic, Inc. - Revenue Breakup by Geography (%), 2017 Figure 11-12: Illumina, Inc. - Revenue Breakup by Geography (%), 2017 Figure 11-13: Quest Diagnostics - Revenue Breakup by Segments (%), 2017